PGNY
PGNY
NASDAQ · Health Care

Progyny Inc

$35.86
+1.02 (+2.93%)
Financial Highlights (FY 2026)
Revenue
1.09B
Net Income
49.68M
Gross Margin
23.6%
Profit Margin
4.5%
Rev Growth
+17.9%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 23.6% 23.6% 37.2% 37.2%
Operating Margin 6.6% 6.0% 16.9% 14.1%
Profit Margin 4.5% 4.3% 10.4% 11.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.09B 928.13M 328.65M 361.52M
Gross Profit 258.51M 219.32M 122.33M 134.57M
Operating Income 72.42M 55.30M 55.42M 51.06M
Net Income 49.68M 37.93M 34.13M 42.27M
Gross Margin 23.6% 23.6% 37.2% 37.2%
Operating Margin 6.6% 6.0% 16.9% 14.1%
Profit Margin 4.5% 4.3% 10.4% 11.7%
Rev Growth +17.9% +17.9% -2.1% +18.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 534.59M 401.19M
Total Equity — — 927.29M 982.54M
D/E Ratio — — 0.58 0.41
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 76.59M 61.73M 62.54M 73.50M
Free Cash Flow — — 47.89M 44.04M